I am Howard Klein, Publisher and Publisher of THE HOUSE EDGE casino investment site on SA. Tip Ranks ranks me as 68 out of all gaming/leisure analysts, and my success rate is 77% with a 20% average return.
For 30 years I held senior vp and exec VP positions in major casino hotel operations among them Caesars, Ballys, Trump Taj Mahal and have done extensive consulting assignments for many others in the US, including the native American property Mohegan Sun, in Connecticut. I have also done special projects for Caesars Palace in Las Vegas. I was the founder and publisher of Gaming Business Magazine, first ever publication covering the gaming industry and have written extensively about the industry.
My two books are presently sold as Kindle ebooks on the Amazon site: MASTERING THE ART OF CASINO MANAGEMENT and THE GREAT AMERICAN CASINO BAZAAR. I have appeared on industry seminar panels and on national radio and television discussing various aspects of industry growth. I am a graduate of NYU's Stern School of Business and did work toward a Master's degree in economics at the Columbia School of General Studies.
MY INVESTMENT STRATEGY: Due to the necessities of my casino consulting business which encompasses many top gaming companies, I have placed my own gaming portfolio into a blind trust over ten years ago. At that time I instructed my money manager(who is a former industry colleague herself as well as a corporate lawyer and money manager) to follow my gaming investment strategy along these lines. 1. I am a value investor first. Knowing the industry in depth I am able to plumb opportunities and problems others cannot see. Mostly I like to identify price ranges over given periods where I believe the market is asleep and I can buy in at the lowest possible risk. 2. I am a strong believer in management quality. Knowing so many top people in the industry allows me to evaluate which ones I believe have the "right stuff" to move a stock and which are populated by corporate drones. 3. I have instructed my manager never to trade on sugar high spikes in earnings or news per se but use the "string theory" I have developed which in brief, follows a skein of news and earnings releases over set periods of time for each stock and then move in or out. 4. I have instructed her to keep the portfolio diverse with holdings in four basic areas: Casino stocks in Las Vegas, Macau and the regionals, gaming tech stocks with real moats not just cute apps.
Overall I have done immensely well and share my views with SA readers and more specifically with strong recommendations and gaming stock strategy analysis based on my network of industry contacts for subscribers to my SA Premium Site: THE HOUSE EDGE.
John Thomas is a 50-year veteran of the financial markets. He spent 10 years as a financial journalist, ten more years trading for a major investment bank, and another decade running the first dedicated international hedge funds. Seeing the incredible inefficiencies and severe mispricing offered by the popping of multiple bubbles during the Great Crash of 2008, and missing the adrenaline of the marketplace, he returned to active hedge fund management.
With The Diary of a Mad Hedge Fund Trader, his goal is to broaden public understanding of the techniques and strategies employed by the most successful hedge funds so that they may more profitably manage their own money.
He publishes a daily research newsletter, and offers one of the most successful trade mentoring services in the industry. He currently has followers in 134 countries.
In his free time, John Thomas climbs mountains, does long distance backpacks, practices karate, performs aerobatics in antique aircraft, collects vintages wines, reads the Japanese classics, and engages in a wide variety of public service and philanthropic activities.
His career has taken him up to 20,000 feet on Mount Everest, to the edge of space at 90,000 feet in the Cockpit of a MIG-25, and to the depths of a sunken Japanese fleet in the Truk Lagoon.
Why they call him "Mad" he will never understand.
Founded by Dr. Hung Tran, MD, MS, CNPR, (in collaboration with Dr. Tran BioSci analyst, Ngoc Vu, and other PhDs), Integrated BioSci Investing (“IBI) marketplace research is delivering robust returns since inception. To name a couple winners, Nektar Therapeutics and Spectrum Pharmaceuticals delivered profits of 446% and 196% for our subscribers, respectively. Our secret sauce is extreme due diligence coupled with expert data analysis. The service features a once-weekly exclusive in-depth Integrated BioSci article (in the form of research, reports, or interviews), daily individual stocks consulting, and model portfolios. Of note, we’ll increase our price soon (SUBSCRIBE to IBI now to lock in the current price and save money). Click the orange FOLLOW button to receive the FREE real-time alerts on our articles and blogs. To read the FREE once-weekly articles covering promising small-cap bioscience firms, check out www.drtranbiosci.com (and make sure to register for our mailing list). You can read up on Dr. Tran’s background in an in-depth article by following this link. http://www.drtranbiosci.com/p/dr-tran.html "Stellar therapeutics for patients. Differentiated intelligence for investors. Premium valuations for firms."
My purpose is to purchase great companies at great value. My goal is to assemble a portfolio of dividend growth stocks that will continue to pay and increase their dividends annually in order to achieve my goal of financial independence. Financial independence for me is to have my dividends cover my living expenses come retirement (or sooner would be better!).
I have called my portfolio the Accelerating Dividends Portfolio. My portfolio consists of the following stocks right now:
Core: HAS, TXN, WYN
Supportive: AMGN, AVGO, O, STAG, STOR
Speculative: T, SKT, PEP
You can read my investment here.
As for myself, I am a part-time, self-educated investor who works a full-time day job as an criminal intelligence analyst. I bring my thought process from my job with me to much of my daily life. I like to ask questions, particularly some that are hard and not really talked about. I like to find data and do analyses in order to support or refute my ideas and answer my questions.
I came across the dividend growth investing model when I was searching for a better way to invest my money. I love and advocate the dividend growth investment model because it has touched and inspired me, made the most sense to me and helps me to sleep well at night.
I have been enthralled over the last few years with finances (if I could change careers, I would move to financial advising in order to pursue this interest full-time). This interest has stirred within me a great desire to learn and although there is always more to learn, I continue to enjoy the challenge of acquiring more knowledge and experience. I enjoy applying what I have learned particularly in my writing here on Seeking Alpha. I also apply many of my analytic skills and thinking to my articles in order to stimulate discussion to get many points of view. This helps me enhance my own opinion, perspective, and thought process. I hope that what I share will be of worth to the Seeking Alpha community.
I hope you will follow me along this journey towards financial independence and accelerating dividends!
Seeking Alpha's product team is responsible for the development of all of our product-related projects from start to finish. These projects include the Seeking Alpha Portfolio apps on the App Store and Google Play, our Real Time email alert product, and optimization across the Seeking Alpha website.
The purpose of this profile is to allow us to share with our readers all new product developments. Please follow us on Seeking Alpha to receive updates. We look forward to your input and feedback!
SA Product Team
My goal is to design and manage a diversified portfolio that provides a growing, relatively safe dividend stream to supplement retirement income. The portfolio includes 30 individual equities and 7 ETFs. The average number of consecutive years of dividend increases is 26. Eight of the companies have S&P credit ratings of AA or higher. Fifteen are rated A+ or higher. Twenty-one are rated A- or higher. One company (WP Carey) is rated BBB. The other 29 are rated BBB+ or higher. I try to buy quality and maintain a long term perspective.
The 30 individual equities are: Johnson & Johnson (JNJ); Microsoft (MSFT); Exxon Mobil (XOM); Apple (AAPL); Walmart (WMT); Automatic Data Processing (ADP); Pfizer (PFE); Merck (MRK); Procter & Gamble (PG); 3M (MMM); Cisco (CSCO); Royal Bank of Canada (RY); NW Natural (NWN); PepsiCo (PEP); Texas Instruments (TXN); Kimberly-Clark (KMB); Qualcomm (QCOM); Simon Property Group (SPG); Clorox (CLX); PPL Corporation (PPL); WEC Energy (WEC); AT&T (T); National Retail Properties (NNN); Realty Income (O); Tanger Factory Outlets (SKT); Enterprise Products Partners (EPD); Brookfield Renewable Partners (BEP); Ventas (VTR); BCE Inc (BCE); WP Carey (WPC).
The 7 ETFs are: Vanguard Total Stock Market Index ETF (VTI); Vanguard FTSE Developed Markets Index ETF (VEA); Vanguard FTSE Emerging Markets Index ETF (VWO); Vanguard High Dividend Yield Index ETF (VYM); Vanguard International High Dividend Yield Index ETF (VYMI); Vanguard Mid-Cap Value Index ETF (VOE); Vanguard Small-Cap Value Index ETF (VBR).
EP Vantage is a forward-looking comment and analysis service tailored to the needs of pharma and finance professionals, focusing on the events that will define the future of companies, products and therapy areas. Written by experienced journalists, EP Vantage provides timely financial analysis of regulatory and patent decisions, marketing approvals, licensing deals, and M&A, giving fresh angles and insight to both current and future industry triggers. EP Vantage is powered by EvaluatePharma, the industry leader in consensus forecasts.
David Zanoni is ranked in the top 1% of blogging analysts on Tipranks.com for performance and accuracy. He focuses on growth & momentum stocks that are reasonably priced and likely to outperform the market over the long-term. David is a graduate of Rutgers University with a B.S. in Management. He is an independent long term investor of quality stocks and uses options for strategy. David believes in the power of innovation, capitalism, and the characteristics of the American spirit: intellect, fortitude, and adaptability to lead our country and the world to growing prosperity. His wants to help make people money by investing in high-quality growth stocks.
Debra Borchardt is a former Vice President of Bear Stearns where she worked for 15 years before its demise. She held a Series 7 and RIA license. She left Wall Street after getting her Masters degree in Business Journalism from New York University to become a financial reporter. Since then, Debra worked at TheStreet.com for eight years and recently launched the financial cannabis news website Green Market Report. She has covered the cannabis industry for over 5 years and is in demand as a moderator at many cannabis conferences due to her knowledge about the sector.
@DavidAltonClark - Top Financial Expert per http://Tipranks.com
In addition to investing in and writing about stocks for the better part of the past decade, I'm currently a licensed Texas REALTOR® with 20 years in the business. I was formerly a FINRA registered securities representative in the oil and gas industry, worked in the banking industry, and as an auditor and consultant for a major accounting firm. I received my Bachelor's degree in Accounting (With Honors) from the University of Texas - San Antonio.
I've managed my portfolio for the past 25 years, including successfully navigating the 2000 and 2008 bubbles, so I understand the full cycle the market can take. My professional background has provided me with an intimate knowledge of corporate financial statements and how the companies actually made money.
I have been ranked #1 out of over 8500 financial bloggers and professional analysts tracked by TipRanks for a majority of the past three years. I am currently the most highly followed Financial Expert on TipRanks with over 6,300 followers. I have consistently been correct 75% of the time with my picks returning approximately 27.3% on an annual basis since 2011. I was thrilled to be featured in an article in BARRON'S for my stock picking performance in 2016.
Click this Globe and Mail and Barron's link for articles regarding my performance and background.
To follow me click the "Follow" button! (Easy right?)
Kumquat Research is a college student and fund manager who has been investing for 6 years. He writes mostly about the technology sector and about event-driven and momentum opportunities across various industries and sectors. He is currently studying for degrees in both finance and computer science at the University of Maryland. Some of his interests include technology, programming, drumming, video games (developing and playing) and astronomy. Articles written and comments posted by Kumquat Research are NOT financial or investment advice, and only express his opinion. Do your own due diligence!
2016 returns: 22.40%
2017 returns: 22.05%
The REIT Forum is in the top 1% on TipRanks: http://bit.ly/cwmftip
The REIT Forum focuses on risk-adjusted returns with a defensive strategy. With a strong background in accounting and finance, fundamentals are a top priority. Buying a strong company with great fundamentals at an attractive price is a good long-term strategy. The subscription platform allows me to do a few things very well. It allows me to share the research I’m doing for my own investment decision making. It allows me to communicate rapidly with investors that are willing to pay for my best work.
The REIT Forum includes:
Subscriber only – Extensive research (thousands of articles) on 50+ companies, buy targets, and forward looking analysis.
Subscriber only - Weekly articles comparing 50+ preferred shares and finding the best opportunities. Preferred shares offer investors high yields with relatively lower risk.
Subscriber only - Analysis and updates on the REIT sectors. This includes finding the best investments within a subsector.
Subscriber only – Risk ratings and dividend sustainability research.
What is my view on risk?
The traditional view is to see earning excess returns as compensation for taking on high levels of risk. I believe it is far better to focus on earning returns from catching market failures. These failures happen due to poor liquidity and investors (including analysts) working with incomplete information. I believe that by knowing the individual companies well, the investor can step in when the “risk” is heavily skewed in favor of “returns”.
I do not try to generate higher returns, I try to generate more consistent returns by reducing the downwards risk. Occasionally that results in exceptionally high returns when something corrects, but it also means I am willing to pass on several decent opportunities because I want the risk/return profile skewed heavily in my favor.
I have a twenty year background in equity research and investing, fifteen of which have been spent in directional hedge funds and before that I was a sell side analyst. I focus on the financial services sector globally and also write about general market issues, economics and geopolitics, often though not always with a financials slant.
Damon Verial is a statistical analyst who uses his skills to research stocks, options, and investment strategies. In addition, Damon is the writer of Copy My Trades, a trade-alert, subscription-based newsletter, available at his personal website. He is also the writer of Exposing Earnings, an in-depth earnings prediction service here on Seeking Alpha.
Damon makes his living as a gap trader, an earnings trader, and an interday trader. In his free time, he writes for Seeking Alpha, where he focuses on seasonal investing, market timing, and earnings analyses.
Damon has written several successful stock analysis algorithms, including algorithms that can predict gap closure, intraday patterns, and news overreactions. They will soon be publically available for subscribers.
Damon’s undergraduate education was in statistics and mathematics at the University of Washington; his graduate education was in psychology at National Taiwan University. He currently lives in Fukuoka, Japan.
Follow me by clicking the "Follow" button. Easy,. right?
Chris (email@example.com) is an Hon B.Sc graduate (with distinction) in Science and Economics with over 15 years in investing experience. He holds a PMP (Project Management Professional) designation. TipRanks Top 100 Blogger of 2015 (also 2013, 2014). Seeks undervalued, unappreciated value stock ideas. Follows Warren Buffett's mantra: do not lose money. For a better mobile experience on Seeking Alpha click on the top right menu icon on most browsers and select "request desktop site".
Jeff is the President of NewArc Investments Inc., manager of both individual and institutional investments. Jeff is a registered investment advisor, and portfolio manager for NewArc's investment programs. Jeff is a former college professor with a hands-on, real world attitude. His quantitative modeling helped inform state and local officials in Wisconsin for more than a decade. A Public Policy analyst, he taught advanced research methods at the University of Wisconsin, and analyzed many issues related to state tax policy. Jeff began in the financial business as Research Director for trading firm at the Chicago Board Options Exchange. He investigated anomalies in the standard option pricing models, taught classes for beginning options traders, and developed new forecasting techniques. In 1991 he established a general research consultancy, working with professional traders at all of the Chicago financial exchanges. In 1998 he started NewArc Investments, Inc. Jeff has a commitment to the specific needs of individual investors. It is not a one-size-fits all approach, but one that emphasizes the unique circumstances of each client. Jeff also serves on the board of two small technology companies (currently Chairman at one). He is occasionally as an expert witness in legal cases involving financial markets and hedging.
I only look at stocks that have the possibility to double over a twelve month period and stocks in which the risk/reward ratio payout is high. In addition I focus on swing trade opportunities. I focus more on valuations and risk/reward metrics as opposed to what make companies tick. I have been a professional investor for over 20 years and during the past several years an economics analyst and financial writer for capital.gr, the biggest economic news portal in Greece. I have managed money from time to time and have also done some seed venture capital projects in the past.
Bert Hochfeld is a convicted felon. He was convicted in 20212 of misappropriating funds from a hedge fund that he operated.
Mr. Hochfeld graduated with a degree in economics from the University of Penssylvania and received an MBA from Harvard. Mr. Hochfeld has had a long career in the tech world working for such firms as IBM, Memorex/Telex, Raytheon Data Systems and BMC Software. Starting in the 1990's, Mr. Hochfeld worked as a sell side analyst and won awards from the WSJ for his coverage of the software space. In 2001, Mr. Hochfeld formed his own independent research company, Hochfeld Independent Research Group, which provided research services to major instiutions including Fidelity, Columbia Asset, SAC Capital and many other prominent instiutions and hedge funds. He also operated the Hepplewhite Fund, a hedge fund that specialized in tech investment. In the 5 years ending in 2011, Hepplewhite Fund was rated the best performing small cap fund by Hedge Fund Research, and independent 3rd party firm that specializes in ranking managers.
In 2016, Mr. Hochfeld formed Ticker Target Investments, LLC. Ticker Target is the vehicle that Mr. Hochfeld uses to provide clients with investment consulting services and which publishes a newsletter and model portfolio, available to subscribers. Overall, Ticker Target keeps tabs on about 500 names in the space and is always investigating new investment opportunities. Mr. Hochfeld has published more than 300 articles on Seeking Alpha, all of them dealing with companies in the information technology space.
David White is a software/firmware/marketing professional and a long time investor. He has worked in the networking field, the semiconductor equipment field, the mainframe computer field, and the pharmaceutical/scientific instrumentation field. He has bachelor's degrees in bioresource sciences and biochemistry from U.C. Berkeley. He is a former Ph.D. student in biochemistry. He has done significant graduate work in EECS and business at Stanford (through SITN) and UC Santa Cruz. He was awarded a Certificate in Advanced Software Systems (about 1/3 of an MS in EECS) by the Stanford Computer Science Department. He also took most of Stanford's undergraduate Computer Science curriculum. He has been nominated for at least three separate Nobel Prizes (Economics and Peace). He came extremely close to winning the 2014 Nobel Prize in Economics. There are about 3000 nominations for each prize; but since the same people are often nominated multiple times the 3000 nominations lead to only about 250 to 350 nominees worldwide in a given year. With about 7.5B people in the world, the odds of getting three separate nominations are about 1 in 10**22. I also was a Research Fellow for Dr. Stanley Prusiner on the Scrapie project that won the Nobel Prize in Medicine. I probably had little to do with it; but I still get bragging rights.
Sure Dividend helps individual investors find high quality dividend growth stocks with strong competitive advantages suitable for long-term holding.
To this end, we created our Seeking Alpha exclusive service Undervalued Aristocrats. Undervalued Aristocrats finds the safest dividend growth stocks trading at undervalued prices. Click here to learn more.
Tools and Business Reviews to help you find only GREAT stocks: those with rising, recurring revenues and durable competitive advantages. Learn more about our low cost, high value membership today!
Quad 7 Capital, parent company of Quad 7 Research, Quad 7 Partners, and Quad 7 Poker, was founded in 2017 by a team that consists of a long time investor, health researcher, financial author, professor, professional poker player, and politician. For investors and traders, Quad 7 Capital will soon be launching its BAD BEAT Investing Service, focused on extreme value, and leveraging news driven events for rapid return swing trades.
The company has expertise in business, policy, economics, mathematics, game theory and the sciences. The company has experience with government, academia, and private industry. Quad7Capital.com covers a wide range of sectors and companies, with particular emphasis on news related items and mini-analyses on growth companies, cryptocurrencies, REITS, biotechnology/ pharmaceuticals, precious metals, blue chips and small-cap companies. It further offers money saving tips and market news.
Quad 7 Partners is the driving force behind the overall focus on current events, earnings, and timely developments, while Quad 7 Research aims to conduct several in depth analyses per month to identify misplaced market bets, and deep value situations. We are on Stocktwits, and Twitter under username _Quad7Capital_, and on Facebook and TalkMarkets under Quad7Capital.
The Clinically Sound Investor is a pharmacist with a PharmD and a BA in psychology. He has worked across the spectrum from very small independent and hospital pharmacies to the some of the largest retail corporations and medical centers in the nation, as well as experience in specialty and mail order settings. Fascinated by watching the rise of Walmart and Apple after 2008, he now follows the advice "know thyself" and puts expertise of understaning scientific literature to research biotechnology stocks. His investments early on were driven by binary events such as FDA Advisory Committee meetings and PDUFA dates (approvals). Despite initial successes, there were too few of these events, so he expanded into predicting Phase II/III trial results. His writings should not be considered financial advice or the basis for investment decisions. While his interpretations of clinical trial results--which may be overlooked or even thoroughly misunderstood by Wall Street--could be helpful, they're only as good as the original reports they come from. Although written by scientists and doctors, there will always be a slant from the sponsoring company, or worse (like, say, missing data...).
Bob is retired from a career in law enforcement including more than 20 years as an instructor of Investigative Interviewing. He is a Dividend Growth investor using dividend yield from low beta stocks for income and preservation of capital. Bob has self managed his portfolio since early in 2011. He hopes to encourage discussion among those already in retirement and receiving income from their portfolios particularly those facing or about to face Required Minimum Distributions (RMDs).
Bob is a stronger believer in having developing a personal portfolio business plan. He restricts his equity investments to stocks to those with investment grade credit of BBB or higher. He believes in set percentage caps when investing in non-defensive sectors.
Bob believes it is important to invest in holdings that are recession proven.
I am a dividend investor and look for undervalued investments in the stock market. I identify misunderstood and undervalued equity investments and hold those securities until their price approximates my estimate of intrinsic value. I am a long-term investor only.
I am building a $100,000 high-yield income portfolio. I am running this portfolio as an experiment to see if long-term sustainable income can be generated from a diversified pool of high-risk, high-yield securities. I am willing to accept high risk in order to meet my performance goals.
Alex Pettee, CFA. President & Portfolio Manager.
Hoya Capital Real Estate is a Connecticut-based Registered Investment Advisor that focuses on research of the commercial real estate industry, and advisory of well-balanced public real estate equity portfolios. All of our research is for educational purpose only, always provided free of charge exclusively on Seeking Alpha. Recommendations and commentary are purely theoretical and not intended as investment advice. Information presented is believed to be factual and up-to-date, but we do not guarantee its accuracy and it should not be regarded as a complete analysis of the subjects discussed.
The writer is a long term value investor and M.Sc graduate in Financial Markets with over 10 years experience. Value can be found in both long and short ideas and uses options to enhance the risk-return profile of investment ideas.
Disclaimer: This article provides opinions and information, but does not contain recommendations or personal investment advice to any specific person for any particular purpose. Do your own research or obtain suitable personal advice.